N,N-Dimethyl(3-pyrrolidinyl)methanamine, 95.0%, 1g

1-Vinylazepan-2-one (stabilised with HO-TEMPO), 97.0%, 100g

4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid, 99%, 50mg

Hydride terminated polydimethylsiloxane cSt 1000, 100g

1,11-Dibromoundecane, 96%, 5g

2-(2-Ethoxy-4-formylphenoxy)-n,n-dimethylpropanamide, 97%, 250mg

6-Fluoro-2-methoxy-3-methylbenzoic acid, 95%, 1g

2'-Methylformanilide>98.0%(GC)25g

2,5-Dioxopyrrolidin-1-yl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanoate, 95+%, 5g

METHYL 4-AMINO-3,6-DICHLOROPICOLINATE, 95.0%, 25g

Imidazo[1,2-a]pyridine-7-carbaldehyde, 95.0%, 100mg

Ethyl 5-amino-3-bromo-2-methylbenzoate, 98%, 10g

CDTA, min. 99%, pa, ACS, 500 g, plastic packaging.